A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Damon Reed, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Memorial Sloan Kettering at Basking Ridge (limited Protocol Activities)
Basking Ridge, New Jersey, United States
Recruiting - Memorial Sloan Kettering at Monmouth (limited Protocol Activities)
Middletown, New Jersey, United States
Recruiting - Memorial Sloan Kettering at Bergen (limited Protocol Activities)
Montvale, New Jersey, United States
Recruiting - Memorial Sloan Kettering at Suffolk-Commack (limited Protocol Activities)
Commack, New York, United States
Recruiting - Memorial Sloan Kettering at Westchester (limited Protocol Activities)
Harrison, New York, United States
Recruiting - Memorial Sloan Kettering Cancer Center (all Protocol Activites)
New York, New York, United States
Recruiting - Memorial Sloan Kettering at Nassau (limited Protocol Activities)
Uniondale, New York, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Mar 2026
- Primary completion
- 31 Mar 2028
- Completion
- 11 Mar 2028
- Last update posted
- 17 Mar 2026
- Registered enrollment
- 45
- Registry id
- NCT07477457
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.